BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29071776)

  • 21. Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis.
    Jung J; Yoon SM; Han S; Shim JH; Kim KM; Lim YS; Lee HC; Kim SY; Park JH; Kim JH
    BMC Cancer; 2015 Dec; 15():987. PubMed ID: 26681337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors.
    Franck M; Schütte K; Malfertheiner P; Link A
    World J Gastroenterol; 2020 Jan; 26(1):86-96. PubMed ID: 31933516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
    Blank S; Wang Q; Fiel MI; Luan W; Kim KW; Kadri H; Mandeli J; Hiotis SP
    Ann Surg Oncol; 2014 Mar; 21(3):986-94. PubMed ID: 24232510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 28. The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels.
    Fu CC; Wei CY; Chu CJ; Lee PC; Huo TI; Huang YH; Chao Y; Hou MC; Wu JC; Su CW
    J Formos Med Assoc; 2023 Jul; 122(7):593-602. PubMed ID: 36456455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of Pre-transplantation Serum Alpha-Fetoprotein Levels in Hepatocellular Carcinoma Recurrence.
    Montalvá EM; Cantos M; Boscà A; Rubín A; Vinaixa C; Granero P; Maupoey J; López-Andújar R
    Transplant Proc; 2016 Nov; 48(9):2966-2968. PubMed ID: 27932120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
    Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
    Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems.
    Zhang XF; Qi X; Meng B; Liu C; Yu L; Wang B; Lv Y
    Eur J Surg Oncol; 2010 Aug; 36(8):718-24. PubMed ID: 20538423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
    Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
    Yang SL; Liu LP; Yang S; Liu L; Ren JW; Fang X; Chen GG; Lai PB
    Br J Surg; 2016 May; 103(6):716-724. PubMed ID: 26996727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
    Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
    Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass.
    Chan SL; Mo F; Johnson PJ; Siu DY; Chan MH; Lau WY; Lai PB; Lam CW; Yeo W; Yu SC
    HPB (Oxford); 2014 Apr; 16(4):366-72. PubMed ID: 23980880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?
    Hsieh CB; Chen TW; Chu CM; Chu HC; Yu CP; Chung KP
    World J Gastroenterol; 2010 Jun; 16(24):3049-55. PubMed ID: 20572309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in serum α-fetoprotein level predicts treatment response and survival in hepatocellular carcinoma patients and literature review.
    Chou WC; Lee CL; Yang TS; Huang CY; Teng W; Tseng YT; Chen JS; Lin YC; Hou MM; Chang HH; Chia-Hsun Hsieh J
    J Formos Med Assoc; 2018 Feb; 117(2):153-163. PubMed ID: 28392193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology - a prospective study.
    Chaminda SR; Suchintha T; Anuk NM; Supun DA; Bhagya GM; Habarakada LCA; Janaka SH
    BMC Gastroenterol; 2017 Dec; 17(1):142. PubMed ID: 29207969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
    Worland T; Harrison B; Delmenico L; Dowling D
    J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.